A regional healthcare sponsor is underwriting the acquisition of a Thai medical facility group comprising specialized clinics and ambulatory centers. While the transaction maintains a nominal Thai majority shareholding structure (51%), the transaction team must verify whether Thai shareholder funding arrangements satisfy enhanced anti-nominee evidentiary standards under Department of Business Development (DBD) Order No. 2/2569 before change-of-control execution [1].
01. Regulatory Gate: Foreign Business Act (FBA) & DBD Order 2/2569
Thailand's Foreign Business Act (FBA B.E. 2542) restricts foreign majority ownership in restricted service and healthcare-related businesses unless specific exemptions, Foreign Business Licences (FBL), or Board of Investment (BOI) promotional privileges apply [2]. Transaction teams must assess the specific activities effectively carried out by the target entity to establish its precise statutory positioning.
Historically, transaction diligence often treated a compliant shareholder register (showing 51% Thai equity) as sufficient evidence of statutory compliance. However, following the enactment of DBD Order No. 2/2569 (effective August 1, 2026), commercial registration filings involving foreign participation or foreign authorized directors trigger rigorous capital-substantiation requirements. The registrar requires an investment explanation and three months of bank statements from the relevant Thai investors making the investment payment and the relevant receiving representative or juristic person, supporting verification of investment capacity and the payment chain [1]. Furthermore, the registered shareholder position is evidenced, but the underlying ownership and funding position remains subject to the applicable documentary verification.
| Regulatory Condition | Evidence State | State |
|---|---|---|
| Registered foreign shareholding | Current shareholder register | VERIFIED |
| Thai shareholder capital funding | Bank statements missing | MISSING |
| Medical facility licences | MOPH facility permits active | VERIFIED |
| DBD 2/2569 payment-chain evidence | Documentation incomplete | MISSING |
| Change-of-control filing position | To be confirmed against closing sequence | UNRESOLVED |
02. Evidence Gap & RFI Generation
Cross-referencing the data room reveals an evidence gap between the registered ownership structure and the underlying capital substantiation records:
The engine does not accept formal registration records at face value when mandatory payment-chain evidence is absent.
The target's FBA position and change-of-control registration requirements remain unresolved.
03. Financial Underwriting Treatment
Because regulatory applicability remains unresolved and the supporting evidence is incomplete, the engine gates downstream financial modeling:
| Underwriting Output | State |
|---|---|
| Regulatory exposure | CONDITIONAL |
| Applicability | UNRESOLVED |
| Financial exposure | UNQUANTIFIED |
| Valuation | BLOCKED |
| Transaction allocation | PENDING |
AseanPrimer structures the Thai FBA and DBD analysis as a traceable sequence: Condition → Evidence → Evidence Gap → RFI → Financial Status → Transaction Allocation. The objective is not to replace legal review, but to prevent unresolved ownership and nominee exposure from being propagated into the financial model. No restructuring cost, remediation reserve, or contingency assumption is inserted into the valuation model until the underlying shareholder funding evidence is sufficiently resolved.